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Abstract
Background: Tissue culture-adapted Tulane virus (TV), a GI.1 rhesus enteric calicivirus (ReCV), and a mixture of GII.2 and GII.4
human norovirus (NoV)-containing stool sample were used to intrastomacheally inoculate juvenile rhesus macaques
(Macaca mulatta) in order to evaluate infection caused by these viruses.
Methodology & Findings: Two of the three TV-inoculated macaques developed diarrhea, fever, virus-shedding in stools,
inflammation of duodenum and 16-fold increase of TV-neutralizing (VN) serum antibodies but no vomiting or viremia. No
VN-antibody responses could be detected against a GI.2 ReCV strain FT285, suggesting that TV and FT285 represent
different ReCV serotypes. Both NoV-inoculated macaques remained asymptomatic but with demonstrable virus shedding in
one animal. Examination of duodenum biopsies of the TV-inoculated macaques showed lymphocytic infiltration of the
lamina propria and villous blunting. TV antigen-positive (TV+) cells were detected in the lamina propria. In most of the TV+
cells TV co-localized perinuclearly with calnexin – an endoplasmic reticulum protein. A few CD20+TV+ double-positive B
cells were also identified in duodenum. To corroborate the authenticity of CD20+TV+ B cells, in vitro cultures of peripheral
blood mononuclear cells (PBMCs) from healthy macaques were inoculated with TV. Multicolor flow cytometry confirmed the
presence of TV antigen-containing B cells of predominantly CD20+HLA-DR+ phenotype. A 2-log increase of viral RNA by 6
days post inoculation (p,0.05) suggested active TV replication in cultured lymphocytes.
Conclusions/Significance: Taken together, our results show that ReCVs represent an alternative cell culture and animal
model to study enteric calicivirus replication, pathogenesis and immunity.
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Introduction
Caliciviruses (CV) are small, non-enveloped, icosahedral viruses
with a ,7.5–8.5 kb positive sense, single stranded, polyadenylated
RNA genome. The Caliciviridae family consists of five established
genera, Norovirus, Sapovirus, Lagovirus, Vesivirus and Nebovirus. Rhesus
enteric CVs (Recovirus), St. Valerian-like viruses (Valovirus) and
chicken CVs represent three additional, yet unassigned CV genera
[1–3]. Noroviruses (NoV) are important etiologic agents of acute
gastroenteritis in humans and account for the majority of
nonbacterial gastroenteritis outbreaks as well as .50% of all
food-related gastroenteritis outbreaks [4,5]. NoVs can be sub-
divided into five genogroups (GI-V) and at least 33 genotypes
[6,7]. No robust cell culture or in vivo model exists to study human
NoVs.
The first attempt to develop a primate model for human NoV
gastroenteritis dates back to 1978 when Wyatt and colleagues
induced asymptomatic infection of chimpanzees by the Norwalk
virus [8]. Since then, further efforts have been made with porcine,
bovine, murine and other animal hosts including non-human
primate (NHP) species to establish a model that would resemble
human NoV gastroenteritis [9–26]. Despite that substantial
achievements have been made with these models, there is still
a demand for another alternative that would simultaneously
address human NoV-induced clinical illness as well as reflect
biological features of human NoVs including their genetic,
antigenic and HBGA diversity while being utilized in vivo and in
vitro.
Our group recently discovered and characterized a new group
of enteric CVs of rhesus monkey host origin with the proposed
name Recoviruses (ReCVs) [1,27,28]. Enteric CVs frequently
infect colonies with captive NHPs [1,19,27,29,30]. These reports
are based on detection of serum antibodies, electron microscopy or
presence of viral RNA in stool samples. The extent of ReCV
seroprevalence measured by VN antibodies (as high as 80%) in
NHPs colonies is conditioned by host species, age, type of housing
and colony [Sestak and Farkas, unpublished]. It is not clear,
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reflects CV interspecies transmission or cross-reactivity between
CVs of different primate hosts [19,27]. Studies conducted with
human NoV-inoculated NHPs suggest that there are differences in
susceptibility to infection not only among different host species but
also within species – likely caused by individual genetic resistance
factors although possible differences in adaptive immunity play an
important role as well. While some primates remain asymptomatic
after infection, others exhibit diarrhea, vomiting, and dehydration,
resembling the clinical course of human NoV gastroenteritis
[8,10,12,31]. Robust, virus-specific seroconversion and virus
shedding in stools up to three weeks post inoculation have only
been reproduced in NHPs. In order to induce symptomatic
infection, serological and HBGA pre-screening of candidate
animals need to be considered prior to experimental challenge.
The main objective of this study was to explore the suitability of
juvenile rhesus macaques as a TV infection model to study enteric
calicivirus replication, pathogenesis and immunity.
Results
Experimental inoculation of juvenile rhesus macaques
with TV induces clinical symptoms of disease
Intragastric inoculation of TV of two of the three juvenile
macaques (HC55 and HI77) resulted in diarrhea and fever within
two days after virus inoculation (Fig. 1) whereas no clinical
symptoms were observed for HB61 despite that all three macaques
shed TV. The presence of viral genome was measured in cell-free
plasma by qRT-PCR. No vomiting and viremia was detected in
any of the animals. All three TV-inoculated animals shed the virus
for at least 8 days with peak shedding levels of .10
5 TV-RNA
copies per gram of stools in HB61 and HC55 and $10
4 TV-RNA
copies per gram of stools in HI77 (Fig. 2). Considering that
juvenile macaques produce on average 80620 grams of stool
daily, the amount of virus shed in HC55 and HB61 macaques
exceeded the amount received via inoculum (Tables 1 and 2).
No clinical symptoms of diarrhea and fever were observed in the
two NoV-inoculated macaques although GI96 met at one time
point the definition of ‘‘borderline’’ fever (102.5 F). Viral RNA
was detected in fecal specimens from macaque HB11 up to PID 13
and macaque GI96 up to PID 4 by strain-specific nested RT-PCR
(Table 2). Both GII.2 and GII.4 viruses were shed in macaque
HB11 while only GII.2 virus was detected in macaque GI96.
Likely because a lower sensitivity of the quantitative real-time RT-
PCR (20–200 RNA copies for GII strains per reaction) compared
to nested RT-PCR, only PID 1, 2 and 9 samples from HB11 but
none of the samples from GI96 could be evaluated quantitatively
(Table 2). Considering that juvenile rhesus macaques of 2.5–
4.0 years of age produce daily 80620 grams of stool, the HB11
macaque produced more virus in stools than what was received in
inoculum.
Serum antibody responses to TV
All three TV-inoculated macaques developed a VN serum
antibody response ($4-fold increase) by PID 7 (Fig. 2). VN
antibodies reached their peak at PID 7–9 (1:160–1:640), persisted
at their peak levels up to PID 30–38 after which they gradually
started to decline (Fig. 2). By PID 80, VN antibody levels in all
three TV-inoculated animals dropped to almost pre-inoculation
levels. None of the TV (GI.1 genotype)-inoculated animals
developed VN antibody response against FT285–a GI.2 ReCV.
A rise in NoV-specific antibody responses against Minerva (GII.4)
VLPs could not be detected in the NoV-inoculated macaques
(HB11 and GI96) which had consistent anti-Minerva serum
ELISA antibody titers of 1:50 and 1:800 throughout the
experiment, respectively.
Histopathological changes in small intestine
H&E-stained duodenum tissues from TV- and NoV-inoculated
macaques were compared with tissues from normal, healthy, age-
matched controls (Fig. 3). While no significant damage was seen in
the intestinal epithelium, in both TV- and NoV-inoculated
animals, mononuclear, lymphocytic infiltration was observed in
the lamina propria. In addition, moderate blunting and distention
of the villi was observed in all three TV-inoculated animals (Fig. 3).
No histopathological lesions were observed in control macaque
intestinal tissues.
Visualization of TV in small intestinal biopsies
In order to visualize and to characterize TV-infected cells
directly in small intestine, duodenum biopsies were collected at
PID 3 and studied by confocal microscopy. Antibodies specific to
human T-, B-, epithelial, dendritic, apoptotic cells as well as
Figure 1. Stool consistency and body temperature measure-
ments. Stool consistency measurements indicate onset of diarrhea
(.1.0 red line cut-off) upon inoculation. Two of the three TV-inoculated
macaques (HC55 and HI77) showed symptoms of diarrhea up to post-
inoculation day (PID) 6 and 8. The two human NoV-inoculated animals
(GI96 and HB11) did not show diarrhea. HC55 and HI77 macaques
developed elevated body temperature (.102.5 F; red line cut-off)
during the first two weeks following TV inoculation, while body
temperatures of the other animals remained normal. Definition of
diarrhea scale: (0=normal/dry, 0.5=normal, 1.0=normal/soft, 1.5=pas-
ty, 2.0=semiliquid, 2.5=watery), and fever: (,102.5=normal,
102.5=borderline, .102.5=fever).
doi:10.1371/journal.pone.0037973.g001
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conjunction with TV antibodies (Figs. 4 and 5). Consistent with
the histopathological findings, no TV antigen was detected in
epithelial cells. Nevertheless, numerous TV+ cells were observed
within the lamina propria. No TV+ cells were detected in biopsies
from uninfected control macaques (Fig. S1). Many of the TV
antigens exhibited perinuclear fluorescence while TV-specific
antibodies colocalized with calnexin in some cells (Fig. 5; Fig. S2).
Some of the TV+ cells also stained with CD20, a B cell-specific
marker (Fig. 4C).
Quantitative analysis of in vitro TV-inoculated PBMCs
Because suitability of intestinal endoscopic (pin-head size)
biopsies for quantitative cell phenotypic analysis by confocal
microscopy is limited, in vitro experiments with TV-inoculated
PBMCs obtained from eight healthy macaques were performed to
corroborate the presence of CD20+TV+ B cells in the biopsy
samples and to assess the susceptibility of mononuclear cell
populations such as T and B lymphocytes to TV infection. In vitro
cultures of PBMCs from 8 healthy rhesus macaques were used.
TV and negative control media-inoculated cells were harvested at
2 h, 24 h and 6 days PI and tested by multicolor flow cytometry
and/or qPCR to determine the number of TV+ cells and virus
load. Two populations of interest were identified by flow
cytometry: CD3+ T and CD20+ B cells (Fig. 6A). Based on
distinct subset of CD20+TV+ cells identified within CD20+ B cell
population (Fig. 6A), presented data focus on B cells while T cell
populations and negative controls are shown for comparison
(Fig. 6B, Fig. 7). The two ‘‘parent’’ (CD20+ and CD3+)
populations were further sub-divided into CD20+HLA-DR+,
Figure 2. Virus shedding in stools and virus-neutralizing (VN) serum antibody response following TV inoculation. All of the three TV-
inoculated macaques showed presence of virus-specific RNA in stools (upper panel) and developed VN antibody responses ($4-fold increase) by PID
7 (lower panel). Duration of shedding ranged in TV-inoculated macaques between 8–10 days while reaching the peak of ,10
5 RNA copies per gram
of stools in HB61 and HC55 and ,10
4 in HI77. The detection limit of the assay was 10–100 copies per reaction. Antibody serum levels reached their
peak in all three macaques by PID 7–9 (1:160–1:640) while returned to pre-inoculation levels by PID 80.
doi:10.1371/journal.pone.0037973.g002
Table 1. Rhesus macaques and enteric caliciviruses used for experimental inoculation.
Rhesus Age Virus Inoculum, Genotype Virus Stock Dose per Inoculation
N Macaque [Years] Subspecies & Host of Origin Designation [RNA copies per animal]
1 HC55 2.5 Indian TV, GI.1, rhesus
a M33 3/2 10 ml (160
6)
2 HI77 2.5 Indian TV, GI.1, rhesus M33 3/2 10 ml (1610
6)
3 HB61 2.5 Indian TV, GI.1, rhesus M33 3/2 10 ml (1610
6)
4 HB11 3.0 Indian NoV, GII/2 & GII/4, human
b NF2002, 2003 3 ml (1610
5)
c
5 GI96 4.0 Indian NoV, GII/2 & GII/4, human NF2002, 2003 3 ml (1610
5)
aTulane Virus i.e. rhesus enteric CV;
bHuman NoVs GenBank #s: JQ320072 and JQ320073;
cBacteria-free filtrate of 20% stool suspension in PBS. TV and NoV-inoculated
animals were kept separated in devoted BSL2 rooms. The total dosage of TV was 10
6 viral RNA copies per animal.
doi:10.1371/journal.pone.0037973.t001
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CD3+CD11c+ cells, corresponding to five different B and T cell
subsets, to determine which of these cells, if any, contained the
TV. The distribution of five of the above lymphocyte subsets was
similar between TV-inoculated and media control PBMCs, as well
as between cultures harvested at 24 h and 6 days PI, with
CD20+HLA-DR+ B cell subset being the dominant (Fig. 7A, C).
In both CD3+ and CD20+ cell populations HLA-DR+ cells were
the most abundant, representing over 90% of cells while CD11c+
and/or CD123+ cells represented less than 10%. All of the five
lymphocyte subsets contained TV+ cells, but only the
CD20+HLA-DR+TV+ cells surpassed 2% (p.0.05) of the parent
(CD20+HLA-DR+) population at 24 h PI (Fig. 7B). Moreover, the
proportion of CD20+HLA-DR+TV+ cells increased to .6%
(p,0.05) of the parent population by PID 6 (Fig. 7D). Such an
increased proportion of TV+ cells in cultured PBMCs was
corroborated by qPCR. A significant increase in virus load was
detected within 1–6 days PI while no virus was detected in non-
inoculated controls: The average viral RNA copy number per well
by PID 1 (1.3610
6) and PID 6 (2.8610
6) was higher (p,0.05) than
the RNA copy number measured by 2 hours PI (2.3610
5).
Discussion
Human NoVs are a common cause of epidemic and sporadic
acute gastroenteritis worldwide [4,32]. The prototype Norwalk
virus was discovered in 1972 [33], however NoV research and the
development of prevention strategies have since been hampered
by the lack of robust cell culture system and animal model that
closely mimics the clinical symptoms of NoV gastroenteritis in
humans. Despite these difficulties, NoV VLP vaccines are in early
phase clinical trials [34,35]. Evaluation of these vaccines largely
depends on challenge studies in human volunteers.
Table 2. Virus shedding in stools following experimental inoculation.
Rhesus Virus Virus Duration of Maximum Shedding
N Macaque Inoculum Shed in Stools Shedding [Days] [RNA copies per gram of stools / day]
1 HC55 TV (GI.1) TV (GI.1) 8 113,000 (day 2)
2 HI77 TV (GI.1) TV (GI.1) 9 10,600 (day 3)
3 HB61 TV (GI.1) TV (GI.1) 10 273,300 (day 3)
4 HB11 NoV (GII.2 & GII.4) NoV (GII.2 & GII.4) 13 76,400 (day 9)
5 GI96 NoV (GII.2 & GII.4) NoV (GII.2) 4 NA
a
Virus shedding for the TV-inoculated animals started on day 1 (HC55 and HI77) and on day 2 (HB61). For the NoV-inoculated animals virus shedding started on day 1
(HB11) and day 2 (GI96) as determined by nested RT-PCR. No samples from GI96 were however positive by qRT-PCR and only samples corresponding to HB11 days1 ,2
and 9 were positive and quantitatively evaluated. Considering that juvenile rhesus macaques of 2.5–4.0 years of age produce daily 80620 grams of stool, the three TV-
inoculated and HB11 macaques produced more virus in stools than what they received in inoculum.
anot applicable.
doi:10.1371/journal.pone.0037973.t002
Figure 3. Duodenum biopsies from healthy control and TV-inoculated macaques. A– Duodenum tissue from healthy control macaque
with normal tissue architecture of intestinal villi. Magnification 10x. B– Duodenum tissue obtained at PID 3 from TV-inoculated HC55 macaque:
Superficial mucosa contains diffuse mononuclear cell infiltrate with formation of an intra-epithelial lymphoid follicle. Villi are slightly blunted.
Magnification 10x. C– Superficial mucosa of TV-inoculated macaque contains macrophages, plasma cells and scattered eosinophils. Magnification
40x. D– The brush border (green lining=villi) was preserved in TV-inoculated macaques. Purple blue cells indicate underlying subepithelium (TG2 is
a digestive enzyme).
doi:10.1371/journal.pone.0037973.g003
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itis might be based on infection of animals with human NoVs or
the use of cultivable animal CVs as surrogates. Attempts to
experimentally induce human NoV infection in NHP species such
as common marmosets, cotton top tamarins, cynomolgus
macaques, pigtail macaques, rhesus macaques and chimpanzees
almost invariably resulted in asymptomatic infections [8,10,12,31].
In one study however, a symptomatic infection characterized by
Figure 4. Immunofluorescent confocal microscopy of duodenum biopsies from TV-inoculated macaque HC55. A– The cytokeratin+
epithelial cells (red) did not co-localize with TV (green). The TV+ cells appear in subepithelium i.e. lamina propria (arrows). B– The subepithelial CD3+ T
lymphocytes (red) did not co-localize with TV (green). C– Co-localization of some of the CD20+ B cells (red) with TV (green) is indicated by arrows. D–
The IBA-1+ macrophages (red) did not co-localize with TV (green). Nuclear DNA is in blue. E– The CD11c+ myeloid dendritic cells (red) did not co-
localize with TV (green) while co-localization between CD11c+ and calnexin (blue) markers resulted in purple cell coloration. The co-localization of
TV+ cells with calnexin is indicated by arrows. F– Absence of co-localization between TV (green) and TUNEL (red) markers indicates that TV-infected
cells did not undergo apoptosis. Differential interference contrast (gray) is highlighted for the better visualization of tissue architecture.
doi:10.1371/journal.pone.0037973.g004
Figure 5. Colocalization of TV and calnexin antigens inside the HC55 macaque’s duodenum lamina propria. A– While most of the cells
are calnexin-single-positive, simultaneous presence of both TV (green) and calnexin (red) antigens is seen in some of the (yellowish) cells. DIC–
differential interference contrast. B– Spectral overlap of TV and calnexin antigens is shown by arrows.
doi:10.1371/journal.pone.0037973.g005
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following inoculation with the Toronto virus [12], but these results
have not been confirmed by other studies. Moreover, detection of
CVs or CV antibodies, including NoVs was reported in colonies
with captive NHPs [27,29,30,36]. In captive NHP colonies, CVs
have been detected in stool samples of animals with symptoms of
diarrhea. Recent data suggest an ,80% ReCV seroprevalence in
rhesus macaques housed at three separate U.S. colonies [27,
Sestak and Farkas, unpublished]. While ReCV seroprevalence
rates are high in juvenile and adult rhesus monkeys, other NHP
species exhibit different and/or lower seroprevalence rates. As
suggested, these differences could be due to species-specific
susceptibility/resistance factors such as HBGAs [19]. Considering
the high TV seroprevalence combined with high rates of juvenile
diarrhea-associated morbidity in these colonies, it is suspected that
ReCV infections play an important role in the etiology of NHP
gastroenteritis. Here we examined for the first time whether
experimental challenge of juvenile rhesus macaques with the tissue
culture-adapted prototype ReCV (TV) induces clinical disease.
Although no equivalent inoculum of tissue culture-adapted human
NoV was available, two additional animals were challenged with
human NoV stool suspensions to compare the clinical outcome
between TV- and human NoV-inoculated animals. In order to
increase the chance of infection, both animals were inoculated
with a mixture of GII.2 and GII.4 NoVs. Mixed NoV infections
have been described in oyster-associated human NoV outbreaks
[37]. Also, the existence of recombinant NoVs [38] indicates that
mixed NoV infections do frequently take place.
Two out of three TV-inoculated macaques developed symp-
toms of gastroenteritis (diarrhea, fever and virus shedding in stools
but no vomiting or reduced appetite were noticed) while the third
remained asymptomatic. All three animals shed virus for more
than a week (8–10 PID) even though maximum virus shedding
reached ,10
5 viral copies per gram of stool only in HC55 and
HB61. Quantitative evaluation of virus shed in these two
macaques combined with the daily output of stools (Table 2)
Figure 6. Flow cytometry detection of TV antigens-containing cells in vitro. A– PBMCs isolated from healthy rhesus macaques were used for
in vitro inoculation with TV. After being cultured in vitro for 6 days, cells were sorted out into CD3+ T cell and CD20+ B cell populations. Presence of
TV antigens was detected in CD20+ B cells as shown by histograms (black peak). B– The CD20+ B cells were further subdivided into populations
expressing the HLA-DR, CD11c or CD123 antigens. Presence of TV was revealed predominantly in CD20+HLA-DR+ cells while some of the other
lymphocyte populations including the CD20+CD11c+ and CD20+CD123+ B cells also contained TV antigens.
doi:10.1371/journal.pone.0037973.g006
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virus in the inoculum. Vomiting was not detected as a clinical sign
of TV infection. This could be due to small number of animals in
this study or other reasons. Studies with NoV-infected children
suggest that ,25–30% of these children do not vomit [39,40]. In
addition, still unknown differences between ReCV and NoV
pathogenesis might also be linked with the lack of vomiting in TV-
infected macaques.
All three TV-inoculated macaques developed $4 fold TV-
specific VN antibody responses within 7 days PI, indicating an
early memory response, consistent with low levels of VN
antibodies prior to inoculation. VN antibodies reached their peak
by PID 7–9 in all of the three animals and persisted at high levels
up to 4–5 weeks PI. After 5 weeks PI, VN antibody titers started to
decline, possibly due to absence of re-exposure(s) that take place in
colony animals [14,18]. It is also possible that the binding (ELISA)
antibodies would be detected for much longer period of time than
functional (VN) antibodies. Finally, it is important to highlight that
the low levels (1:40–1:80) of VN antibodies were still present at the
end of the study in TV-inoculated macaques. Consistent with
these results, declining NoV immunity has also been observed in
human volunteers [41,42]. Thus, questions still remain regarding
the longevity, magnitude, class and role of CV antibodies in
protection.
Interestingly, VN antibody responses could not be detected in
any of the TV-infected animals against FT285 a GI.2 ReCV
isolate, indicating that the two strains likely belong to different
serotypes. TV and FT285 ORF2 and capsid proteins share 69% nt
and 74% aa homology (Farkas and Sestak unpublished), which is
comparable with differences between different human NoV
genotypes. If humoral immunity plays a role in protection against
enteric CV infections, our results are translational for NoV vaccine
design since multiple genetic types have been described for both
ReCVs and human NoVs. At present, ,10 cell culture-adapted
ReCVs representing at least three genotypes are available in our
laboratory. Consistent with previous reports, none of the two
human NoVs used in this study caused clinical infection. Since all
macaques secreted type-B HBGA in their saliva (not shown), and
both NoV challenge strains were obtained from a type-B patient, it
was predicted that both strains would replicate in macaques.
However, only GII.2 virus was detected in macaque GI96, while
both Gll.2 and Gll.4 viruses were shed by HB11 (Table 2).
Although duration of shedding in HB11 was suggestive of virus
replication, no antibody responses were detected against Minerva
(GII.4) VLPs. Macaque GI96 had relatively high level (1:800) of
ELISA antibodies at the beginning of the study. This could explain
the complete absence of GII.4 virus shedding in GI96. GII.2 VLPs
were not available to evaluate the GII.2-specific seroresponses in
this study. Low viral loads in stools of Norwalk virus-challenged
rhesus macaques were also reported by Rockx and colleagues [10].
In their study, two animals stopped shedding virus by PID 2 while
one animal shed up to PID 19 while it developed strong antibody
responses. In the same study, marmosets and tamarins, but not
cynomolgus macaques, shed the virus up to PID 4 but did not
develop antibody responses. Taken together, these studies indicate
that NHPs can be subclinically infected with human NoVs but the
infection is very limited and its intensity varies in different species
and individuals.
Histopathological examination of H&E-stained duodenum
biopsies obtained at PID 3 demonstrated lymphocytic infiltration
of the lamina propria in all five inoculated macaques while mild
villous blunting was present in three TV-inoculated macaques.
Figure 7. TV-antigen containing lymphocyte populations in cultured, TV-inoculated PBMCs. A & B– One day-old cultures of TV-
inoculated PBMCs show the trend (p.0.05) for TV antigen expression by CD20+HLA-DR+ B cells. C & D– Six days-old cultures show significant
presence of TV antigens predominantly inside the CD20+HLA-DR+ cells (p,0.05). Several other T and B cell subsets also contain TV while no virus was
detected in negative control, mock-inoculated PBMCs. Asterisks indicate significant differences between the TV-inoculated and control cells.
doi:10.1371/journal.pone.0037973.g007
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histopathology of NoV-infected humans [43–45]. Although no
ultrastructural examination of enterocytes was performed by
transmission electron microscopy, confocal microscopy examina-
tion of intestinal brush border and epithelial layer revealed no
significant damage of enterocytes indicating the possibility that
virus might have translocated into lamina propria without
replicating in enterocytes. This finding differs from what was
reported with human NoV-inoculated gnotobiotic pigs or calves
that showed presence of viral particles inside the enterocytes by
PID 3 [9,46]. Notwithstanding, our results are consistent with
reported findings of human NoV i.v.-inoculated chimpanzees
which showed the presence of NoV antigens in intestinal lamina
propria while exhibiting the signs of asymptomatic virus infection
such as virus shedding in stools and seroconversion [31]. In all of
these studies, enterocyte damage was minimal or undetectable
regardless of the detection of virus antigen raising questions about
CV pathogenesis and their exact host cell tropism. In case of TV-
inoculated macaques, TV antigen-containing cells with peri-
nuclear fluorescence were found in intestinal lamina propria
(Figs. 4 and 5). In many of these cells TV-specific antibodies co-
localized with calnexin, an endoplasmic reticulum marker,
consistent with the formation of replication complexes reported
for feline CV [47].
To determine the authenticity of TV-containing cells, several of
the human-specific cell markers were utilized (Table 3). A few
CD20+TV+ B lymphocytes were identified directly in duodenum
lamina propria by confocal microscopy. Since suitability of
intestinal pin-head-sized biopsies for quantitative cell phenotype
analysis by confocal microscopy is limited, in vitro experiment with
TV-inoculated PBMCs obtained from eight healthy macaques was
performed, utilizing quantitative multicolor flow cytometry, to
determine if CD20+TV+ B cells could be identified in these
cultures (Figs. 6 and 7). The presence of CD20+TV+ B cells was
demonstrated corroborating the confocal microscopy data. Most
of the TV+ cells expressed HLA-DR antigen, suggesting a)
involvement of TV+ lymphocytes in antigen presentation to other
immune cells or b) possibility of activated lymphocytes being
infected. Increased viral RNA load (p,0.05) that was detected in
cultured PBMCs within 24 h following TV inoculation supported
the flow cytometry data and was suggestive of virus replication. In
study by Lay and colleagues, Norwalk virus failed to replicate in
macrophages or dendritic cells derived from human peripheral
blood [48]. A more recent study by Chan and colleagues indicates
however that human NoV binds to the lamina propria and
Brunner’s gland cells of the human duodenum [49]. We have also
incorporated CD123 marker to determine whether some B cells
start to acquire dendritic cell (DC)-like features following their in
vitro exposure to virus. Earlier reports by Bjorck and colleagues
(1998) showed that CD19+ B cells can differentiate into DCs
following cytokine stimulation [50]. Although commonly used as
a DC marker, CD11c is also expressed by activated or leukemic B
cells [51,52]. Recently, a subpopulation of memory B cells was
shown to express CD11c [53]. In our study we observed increased
CD11c expression by TV-infected B cells suggesting the activation
of these cells following TV infection.
The fact that TV was identified in both B and T cells is to some
degree different from findings reported for murine NoVs that
replicate efficiently in macrophage and dendritic cell lines
[13,25,26]. Since Rhesus CD14+ cells can differentiate into
dendritic cells in vitro, it will be interesting to evaluate if these cells
will become permissive to TV infection. In summary, our results
are consistent with findings of human NoV -infected chimpanzees
that remained asymptomatic but showed the presence of NoV
antigen in intestinal lamina propria [31]. Many features of CV
infection in primates such as HBGA-associated genetic suscepti-
bility to infection remain to be elucidated. In this proof-of-concept
study, we demonstrated the potential of rhesus macaques using
ReCV as a diarrheal disease model for human NoV. In future
studies candidate animals will be selected by prescreening for the
specific HBGAs and/or by using newborn SPF or animals
completely naı ¨ve of previous ReCV exposure while using highly
cytopathic ReCV strain for challenge.
Materials and Methods
Ethics statement
Approval for all veterinary procedures in this study had been
obtained from the Tulane University Animal Care and Use
Committee, Animal Welfare Assurance A-4499-01. Animals in
this project were under the full care of veterinarians with the
standards incorporated in the Guide to the Care and Use of
Laboratory Animals (NIH) 78-23 (Revised, 1996). All veterinary
procedures were performed only with sedated animals. Animal
welfare and steps were taken to ameliorate suffering in accordance
with the recommendations of the Weatherall report. The findings
and conclusions in this article are those of the authors and do not
necessarily represent the views of the Centers for Disease Control
and Prevention. This article did receive clearance through the
appropriate channels at the CDC prior to submission.
Animals, procedures and samples collected
Forty juvenile (,4 years-old) candidate rhesus macaques were
identified from a group of 300 based on absence of TV-
neutralizing serum antibodies [27]. Due to unrelated reasons,
selected candidate animals were assigned for the study not
immediately but after a delay, which resulted in low, marginal
but detectable TV seroconversion. Five animals (1:10–1:40 VN
antibodies) with no detectable virus shedding in feces were
included in this study (Table 1). Only simian retrovirus- (SIV,
SR and STLV) and enteric pathogen-free animals were selected
using the diagnostic techniques described elsewhere [54,55]. All
five macaques were inoculated intragastrically and were housed
under biosafety level two (BSL2) conditions. Three macaques were
inoculated with tissue culture-adapted TV and two macaques with
bacteria-free stool suspensions containing a mixture of GII.2 an
GII.4 NoVs (Table 1). Human NoV positive stool samples
(NF2002 and NF2003; GenBank accession numbers: JQ320072
and JQ320073) were collected during two family outbreaks
occurring in May 2002 and March 2003 in Cincinnati, OH,
respectively. The inoculum was prepared from 20% (w/v) stool
suspensions that were clarified by low-speed centrifugation and
filtered using 0.22 mm filters. Aliquots were stored at 280uC.
Upon inoculation, body temperature and stool consistency were
recorded daily up to post-inoculation day (PID) 40. Stool samples
were collected each morning at indicated time points (Fig. 1) from
the individual cage pans that were replaced daily. Diarrhea was
defined above the score of 1.0 according to following key:
(0=normal/dry, 0.5=normal, 1.0=normal/soft, 1.5=pasty,
2.0=semiliquid, 2.5=watery), while fever was defined above the
102.5 F: (,102.5=normal, 102.5=borderline, .102.5=fever).
Samples of blood and plasma were obtained weekly and/or at
indicated time points (Fig. 2) up to PID 80. Based on similar
experiments with gnotobiotic piglets [14], pediatric endoscopy
method was used at PID 3 to obtain ten pin-head-sized biopsies
from the distal duodenum of all five inoculated and two negative
control healthy macaques [56].
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Plasma samples collected from all five macaques were tested for
the presence of virus-specific antibodies. TV-inoculated macaques
(HC55, HI77 and HB61) were tested for the presence and
magnitude of TV virus-neutralizing (VN) antibodies [27]. Briefly,
serum samples were titrated in duplicate wells of 96-well tissue
culture plates (Corning Life Sciences, Lowell, MA) to neutralize
100 TCID50 TV (GI.1) or FT285 (GI.2) ReCVs. To avoid non-
specific neutralization by complement, serum samples were heat
inactivated. Virus/serum mix was incubated at 37uC for 1 h and
transferred into wells seeded with 1610
4 LLC-MK2 cells/well in
duplicate one day prior. Plates were stained with crystal violet at
72 h post infection (Sigma-Aldrich, St. Louis, MO). At this time
point, all cells in the virus control exhibited CPE characterized by
cellular degeneration and detachment. VN antibody titer was
determined as the highest dilution of the serum sample at which
the cell monolayer was at least 50% intact in duplicate wells.
Human NoV-inoculated macaques (HB11 and GI96) were
tested for the presence of NoV-binding (ELISA) antibodies using
human NoV GII.4 (Minerva) virus-like particles (VLPs), as
described previously [27]. Briefly, VLPs diluted in PBS were
coated onto 96-well microtiter plates (Dynex, Immulon, Dynatech)
at 50 ng/well, overnight, at 4uC. Every second row of the 96-well
plate was left uncoated and served as background control. Plates
were blocked with 10% Blotto-PBS for 1 h at 37uC. Serum
samples, two-fold diluted in 1% Blotto-PBS, starting from 1:50
were added to two wells each, and the plates were incubated for
1 h at 37uC. Horseradish peroxidase (HRP)-conjugated goat anti-
rhesus IgG (H+L) (Southern Biotech, Birmingham, AL) was added
at 1:3,500 dilution in 1% Blotto-PBS, and the plates were
incubated for 1 h at 37uC. Following each step, the plates were
washed five times with PBS-0.05% Tween 20 in an automated
plate washer (ELx 405 Auto Plate Washer, Bio-tek Instruments
Inc., Winooski, VT). Finally, TMB substrate (BD Biosciences, San
Jose, CA) was added, the plates were incubated for 10 min at
room temperature and the color development was stopped by 1 M
H3PO4. Optical density (OD) values were recorded by the use of
Tecan Spectra II microtiter plate reader (Tecan AG, Switzerland)
at 450 nm. OD readings for each serum sample/dilution were
determined as the average of difference between values obtained
in the two VLP-coated and two uncoated wells. The cut-off was
determined as the mean plus two standard deviations of the OD
readings of the control (uncoated) wells.
Table 3. Antibodies used for immunofluorescent staining of duodenum biopsy tissues.
Antigen Cell Type/Component Isotype Working Manufacturer Catalog Number
Dilution or Clone
TV calicivirus TV-Infected (primary ab) Rhesus Plasma 1:50 TNPRC
a NA
b
Rhesus IgG-FITC
c TV-Infected (secondary ab) Goat IgGc 1:500 RDI-Fitzgerald RDI-617102012
Human Calnexin Endoplasmic Reticulum Rabbit IgG 1:100 Santa Cruz SC-11397
Human Cytokeratin Epithelial Cell Mouse IgG1 1:50 Biocare Medical CKLMW 8/18
Human Villin Intestinal Brush Border Rabbit IgG 1:3 Cell Signalling Tech. 2369
Human CD3 T-lymphocyte Rabbit IgG 1:100 Biocare Medical CP215C
Human CD20 B-lymphocyte Mouse IgG2a 1:400 Dako M0755
Human IBA-1 Macrophage Mouse IgG1 1:100 Santa Cruz SC-32725
Human CD11c Myeloid Dendritic Cell Mouse IgG 1:10 Biosource 3.9
TUNEL (assay) Apoptotic Cell NA NA Millipore S7165
Human TG2 Tissue Transglutaminase 2
d Mouse IgG1 1:100 ThermoScientific MS-300-P1ABX
Nuclear DNA Nucleus NA 1:1,000 Invitrogen T-3605
aTulane National Primate Research Center,
bnot applicable,
cFluorescein-Iso-Thio-Cyanate,
dDigestive enzyme.
doi:10.1371/journal.pone.0037973.t003
Table 4. Antibodies used for flow cytometry of in vitro cultured PBMCs.
Antigen
Cell Type/
Component Isotype Working Manufacturer Catalog Number
Dilution and/or Clone
TV calicivirus TV-Infected (primary ab) Rhesus Plasma 1:50 TNPRC
a NA
b
Rhesus IgG TV-Infected (secondary ab) Goat IgGc 1:100 RDI-Fitzgerald RDI-617102012
Human CD3 T-lymphocyte Mouse IgG1 1:32 BD Pharmingen 558124, SP34-2
Human CD20 B-lymphocyte Mouse IgG2b 1:32 eBioscience 48-0209-42, 2H7
Human CD123 Plasmacytoid Dendritic Cell Mouse IgG2a 1:8 BD Biosciences 554529, 7G3
Human CD11c Myeloid Dendritic Cell Mouse IgG2b 1:32 BD Biosciences 340714, S-HCL-3
Human HLA-DR Antigen-Presenting Cell Mouse IgG2a 1:32 BioLegend 307625, L243
aTulane National Primate Research Center,
bnot applicable.
doi:10.1371/journal.pone.0037973.t004
Infection Caused by Rhesus Enteric Calicivirus
PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e37973Histopathology, immunohistochemistry and confocal
microscopy
Duodenum biopsies collected at PID 3 were used for
histopathological evaluation of tissue architecture following the
standard H&E staining method [56]. In addition, antibodies
specific to primate T and B lymphocytes, epithelial cells,
macrophages, myeloid dendritic cells, apoptotic cells and endo-
plasmic reticulum protein calnexin (Table 3) were used in
conjunction with TV-specific antibodies (rhesus serum of
$1:1,280 VN antibody titer), to identify the potential TV-infected
cells according to described immunohistochemistry protocols
[56,57].
TV infection of peripheral blood mononuclear cells
(PBMC) with TV
PBMCs were isolated from whole blood of 8 healthy, normal
rhesus macaques by density gradient centrifugation using Lym-
phocyte Separation Medium (MP Biomedicals, LLC, Santa Ana,
CA) and seeded in 24-well cell culture plates coated with collagen
(BD Biosciences, San Diego, CA) at a concentration of 2610
6 cells
per well. Cells were cultured at 37uC, 5% CO2 in RPMI 1640
medium containing 2 mM glutamine, 1 mM sodium pyruvate,
100 U/ml penicillin, and 100 mg/ml streptomycin (Mediatech,
Inc., Manassas, VA) supplemented with 10% heat-inactivated FBS
(Hyclone, Thermo Scientific, Waltham, MA). Immediately after
seeding the cells, half of the wells were inoculated with tissue
culture-adapted TV (10
4 RNA copies per well). Cells were
incubated with TV for up to 6 days before being harvested for
flow cytometry and/or TV-qPCR.
Quantitative ReCV detection
For the detection of TV in fecal specimens or plasma, viral
RNA was isolated from clarified 10% fecal suspensions in PBS or
100 ml of plasma using the QIAampH Viral RNA Mini kit
according to manufacturer’s instructions (Qiagen GmbH, Hilden,
Germany). For TV detection in cultured PBMCs, cells plus media
were processed at 2 h, 24 h and 6 days PI with TV. The samples
corresponding to individual wells of 24-well cell culture plate were
pelleted with high-speed centrifugation (14,000 rpm) and the pellet
stored in RNALater (Ambion, Austin, TX) at 220uC. The
PBMCs were pelleted and washed in RNALater solution one more
time before being used for RNA extraction. Total RNA was
extracted using the RNeasy Plus Micro kit (Qiagen GmbH,
Hilden, Germany). Precipitated RNA from both fecal specimens
and PBMC cultures was eluted in 28 ml of nuclease-free water
(Integrated DNA Technologies, Coralville, IA), and 8 ml of the
sample was used as the template in the RT-PCR. RNA, primed
with both oligo(dT) and random hexamers, was reverse-tran-
scribed into cDNA in 20 ml reaction mixtures using Superscript
TM
III First-Strand Synthesis SuperMix for RT-qPCR (Invitrogen,
Carlsbad, CA) according to the manufacturer’s protocol. For
quantitative real-time PCR, 10 ml of the cDNA product was used
as the template in 50 ml reaction mixtures using Platinum
Quantitative PCR SuperMix-UDG with ROX (Invitrogen)
according to the manufacturer’s protocol. The TV-specific primer
pairs and oligonucleotide probe used were as follows: FW 59-
GAGATTGGTGTCAAAACACTCTTTG (nt position 3,645–
3,669 on the TV genome, EU391643), RV 59-ATCCAGTGG-
CACACACAATTT (nt position 3,820–3,800) and 6-FAM-
AGTTGATTGACCTGCTGTGTCA-BHQ (nt position 3,697–
3,719). PCR reactions were run in duplicate on an ABI 7900HT
Fast Real-Time PCR System (Applied Biosystems, Foster City,
CA) using the following amplification conditions: 2 min at 50uC,
10 min at 95uC, 40 cycles of 15 sec at 95uC, 1 min at 60uC. The
threshold for detection of fluorescence above background was set
at 0.185 within the exponential phase of the amplification curve. A
standard curve was generated for each assay using 10-fold
dilutions (from 10
1 to 10
7 copies) of a linearized plasmid
containing the full TV genome. The detection limit of the assay
was 10–100 copies per reaction. Negative control samples were
run alongside each RNA sample from mock-infected cultures.
Human NoV detection by quantitative RT-PCR
For the detection of GII.2 and GII.4 human NoVs, viral RNA
was extracted from clarified 10% fecal suspensions in PBS with the
MagMax
TM -96 Viral RNA Isolation Kit (Ambion, Foster City,
CA) on an automated KingFisher magnetic particle processor
(Thermo Fisher Scientific, Pittsburg, PA) according to the
manufacturer’s instructions and eluted into 100 ml. Viral RNA
was tested in a GI/GII duplex format using an AgPath-ID
TM
One-Step RT-PCR Kit for Probes (Applied Biosystems, Foster
City, CA) on an 7,500 Realtime PCR platform (Applied
Biosystems). The reaction mix of 25 ml consisted of 400 nM of
each oligonucleotide primer Cog1F, Cog1R, Cog2F, and Cog2R
and 200 nM of each TaqManH Probe Ring 1C and Ring 2 [58].
Cycling conditions included reverse transcription for 10 min at
45uC, denaturation for 10 min at 95uC followed by 45 cycles of
15 sec at 95uC and 1 min at 60uC.
Nested RT-PCR for human NoV detection
Since mixtures of GII.2 and GII.4 human NoVs were used to
inoculate the HB11 and GI96 macaques and RT-PCR assay was
not able to differentiate between the two strains, a nested RT-PCR
was designed to evaluate the strain-specific shedding in collected
stool samples. Briefly, viral RNA was reverse transcribed and
amplified in 20 cycles by generic primers P289/P290 in a 25 ml
reaction (AccessQuick RT-PCR system, Promega, Madison, WI).
One ml of the RT-PCR reaction was used as template in a nested
PCR and amplified with primers 62F/63R (GTGTTGGCAG-
CAGCTCTAGAAATC and GTAACTTCAGAGAGCGCACA-
GAGA, specific for NF2003) and 64F/65R (TCATCAGAACCT-
CATCTGGCCCAA and
AAAGGAGAACAGGGAGTTTGCCTGG, specific for
NF2002) in 25 ml reactions in 35 cycles. Reactions yielded a 215
and a 225 bp product, respectively, which could be differentiated
on a 2% ethidium bromide-stained agarose gel.
Flow cytometry
Cell surface marker and intracellular staining were performed as
follows. PBMC cultures were harvested, low-speed centrifuged
(1,300 rpm), and cell pellets were washed twice with PBS (pH 7.4)
containing 0.1% sodium azide and 0.2% FBS. Fluorochrome-
conjugated antibodies specific to human and/or rhesus macaque
surface molecules (Table 4) as well the rhesus serum used as the
primary antibody against TV, were added to cell suspensions and
incubated in the dark for 30 min at RT. The cells were then
washed twice with 1x Perm/Wash Buffer (BD Biosciences) and
resuspended in 50 ml Perm/Wash Buffer. The permeabilized cells
were stained with the primary antibody against TV for 30 min at
4uC, washed with Perm/Wash Buffer, and stained with the
fluorochrome-conjugated secondary antibody (rhesus IgG-FITC,
#617102012, RDI-Fitzgerald, Acton, MA) for 1 h, at 4uC.
Following staining, cells were washed twice and resuspended in
300 ml of 1x BD Stabilizing Fixative (BD Biosciences). Stained and
fixed cells were stored in 12675 mm polystyrene round-bottom
tubes (Becton Dickinson, Franklin Lakes, NJ) in the dark at 4uC for
up to 48 h until analyzed by flow cytometry. Data were collected
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FACSDiva (BD Biosciences) and FlowJo software (Tree Star,
Ashland, OR). A minimum of 50,000 events were collected per
sample. Gating was set based on the CD3
+ T lymphocyte and
CD20
+ B lymphocyte populations (Fig. 6A). The HLA-DR
+,
CD11c
+, and CD123
+ cell subsets within CD20
+ B cell population
were evaluated for the presence of TV (Fig. 7).
Statistical analysis
Statistically significant differences between proportions of TV
+,
HLA-DR
+, CD11c
+, and CD123
+ cells within CD3
+ and CD20
+
populations of control versus TV-inoculated PBMC cultures were
determined by the Student’s t-test assuming equal variances. A p
value of ,0.05 was considered significant. Statistically significant
differences between TV loads in cultured PBMCs at different time
points after inoculation were also determined using the Student’s t-
test, with a significance level of p,0.05.
Supporting Information
Figure S1 Duodenal biopsy from TV-negative macaque
(A) and from TV-inoculated HC55 animal (B). TV
antibody-specific staining shows an intense, cytoplasmic fluores-
cence in biopsy tissue collected at PID 3 from TV-inoculated but
not from negative control animal.
(TIFF)
Figure S2 Individual channels (corresponding to cal-
nexin and TV immunofluorescent staining) control data.
DIC = differential interference contrast.
(TIFF)
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